Ratnakar Securities Pvt. Ltd.

DR AGARWALS EYE HOSPITAL LTD.

NSE : NABSE : 526783ISIN CODE : INE934C01018Industry : Hospital & Healthcare ServicesHouse : Private

BSE4417.20-64.8 (-1.45 %)

PREV CLOSE ( ) 4482.00

OPEN PRICE ( ) 4360.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 663

TODAY'S LOW / HIGH ( )4301.05 4561.00

52 WK LOW / HIGH ( ) 30167300

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-04 1994

Management Info

Amar Agarwal - Chairman Amar Agarwal - Managing Director

Registered Office

Address 3rd Floor, Buhari Towers, No.4, Moores Road,Off. Greams Road,Near Asan Memorial School,
Chennai,
Tamil Nadu-600006

Phone 044-43787777 / 78

Email info@dragarwal.com

Website www.dragarwal.com

Registrars Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai

Listing : BSE

NEWS

19Mar Dr Agarwals Eye Hospital commences ope
Dr Agarwals Eye Hospital has commenced operation of a new branch located..

30Sep Dr. Agarwalâ€™s Eye Hospital informs a
As per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and t..

28Sep Dr.Agarwals Eye Hospital informs about
Dr.Agarwals Eye Hospital has informed that the Exchange has received Dis..

23Sep Dr. Agarwalâ€™s Eye Hospital informs a
Pursuant to Regulation 30 read with Para B of Part A of Schedule III of..

23Sep Dr. Agarwalâ€™s Eye Hospital informs a
Dr. Agarwalâ€™s Eye Hospital has informed that the exchange has received..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	159.9	546.5
Gross Profit	186	707
Operating Profit	316.9	1235.9
Net Sales	998.3	3971.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Narayana Hrudayalay (BSE) 1913.25 (5.09%)	M.Cap ( in Cr)39099.33
Thyrocare Tech. (BSE) 1022.15 (3.83%)	M.Cap ( in Cr)5416.83
Max Healthcare Inst (BSE) 1233.20 (2.62%)	M.Cap ( in Cr)119885.15
Krishna Inst.Medi (BSE) 679.75 (2.78%)	M.Cap ( in Cr)27199.44
Aster DM Healthcare (BSE) 569.85 (0.96%)	M.Cap ( in Cr)29525.13

Shareholding Pattern

	PROMOTERS	71.9%
	NON-INSTITUTION	24.83%
	MUTUAL FUNDS/UTI	0.09%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
WOC Pharma and Heal...	0.56

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

DR AGARWALS EYE HOSPITAL LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES